ACT Capital Management »

Uipath Inc Cl A shares owned by ACT Capital Management

Quarter-by-quarter ownership of Uipath Inc Cl A (PATH) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Uipath Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Uipath Inc Cl A held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Uipath Inc Cl A by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $770k 47k 16.39

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Uipath Inc Cl A

Vanguard Group
BlackRock
Polygon Management
Susquehanna International
State Street Corporation
Rima Management
Point72 Asset Management
Geode Capital Management
Norges Bank Investment Management
Mirae Asset Global Etfs Holdings
Federated Investors
Alphabet
Jane Street
UBS Group
Dimensional Fund Advisors

View all funds holding Uipath Inc Cl A